+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Injectable Ketamine Market - Global Forecast 2025-2030- Product Image
Injectable Ketamine Market - Global Forecast 2025-2030- Product Image
Sale

Injectable Ketamine Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6134484
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Injectable ketamine is redefining clinical care by bridging psychiatry, anesthesiology, and pain management, presenting decisive opportunities for medical institutions and industry stakeholders to proactively adapt to shifting therapeutic paradigms and regulatory landscapes.

Market Snapshot: Injectable Ketamine at a Strategic Crossroads

The global injectable ketamine market is undergoing rapid transformation, driven by its expanded role from traditional anesthesia to advanced treatments for pain management, post-traumatic stress disorder, and treatment-resistant depression. Market growth is supported by evolving formulation and delivery innovations, increased real-world application beyond surgery rooms, and progressive regulatory recognition. Emerging regions and specialized infusion center networks are further accelerating the adoption of versatile ketamine-based therapies, supported by growing investment in evidence generation.

Scope & Segmentation: Comprehensive Market Coverage

This market research report delivers in-depth analysis and forecasts based on robust segmentation and geographic coverage. Stakeholders will find actionable insights into the dynamics underpinning each facet of the market, including technologies and end-use environments:

  • Indication: Includes anesthesia, pain management, post-traumatic stress disorder, and treatment-resistant depression, each representing distinct clinical applications and growth drivers.
  • Product Type: Differentiates esketamine (brand and generic) and racemic ketamine, highlighting product access, competitive positioning, and promotional variation.
  • Route: Encompasses intramuscular injection and intravenous infusion, reflecting user preferences for dosing precision or operational simplicity.
  • End User: Covers ambulatory surgical centers, hospitals, and outpatient clinics, each with distinct procurement and compliance requirements.
  • Distribution Channel: Analyzes hospital and retail pharmacy networks, affecting patient access and inventory strategies.
  • Formulation: Details prefilled syringe and vial formats, which offer differing advantages in sterility, dosing, and operational workflow.
  • Regions: Provides insights into the Americas (including United States, Canada, Latin America), Europe, Middle East, Africa, and Asia-Pacific, with highlights on local trends, infrastructure maturity, and technology adoption. Major subregions are detailed, encompassing key economies across all continents.
  • Key Companies: Evaluates the strategies of leading companies such as Pfizer Inc., Hikma Pharmaceuticals PLC, Fresenius Kabi AG, Viatris Inc., Aspen Pharmacare Holdings Limited, Mallinckrodt Pharmaceuticals Holdings, Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, B. Braun Melsungen AG, and Baxter International Inc.

Key Takeaways for Senior Decision-Makers

  • Injectable ketamine is transitioning from a surgical anesthetic to an integrated solution for complex mental health and pain pathologies, fostering interdisciplinary collaboration in care delivery.
  • Innovations in formulation, administration, and delivery are enhancing patient safety profiles and broadening eligibility for a wider spectrum of clinical populations.
  • The rise of dedicated infusion centers and telehealth monitoring is democratizing treatment access, improving flexibility in patient management, and reinforcing best-practice standards.
  • Strategic alliances among leading pharmaceutical and biotech firms are yielding advanced production solutions, continuous pipeline progression, and widening regional reach.
  • Regional differentials in policy, reimbursement, and healthcare infrastructure require stakeholders to adopt localized market strategies to capture growth.
  • The increasing prominence of generic esketamine is intensifying pricing competition, expanding access, and requiring dynamic lifecycle management from both innovators and entrants.

Addressing Tariff Impact Across the Injectable Ketamine Value Chain

Impending United States tariff updates are expected to shift procurement and pricing landscapes, directly impacting manufacturers, distributors, health systems, and payers. Proactive response strategies include sourcing diversification, strategic partnerships, and value-based contracting models to stabilize supply and insulate patients from cost volatility. Distribution networks are adapting to evolving trade requirements by re-examining logistics and supplier agreements to ensure uninterrupted access.

Methodology & Data Sources

Findings in this report result from a rigorous multi-phase methodology, combining comprehensive secondary research with primary interviews of key thought leaders and commercial stakeholders. Data triangulation ensures validated insights. Quantitative and qualitative inputs were quality-checked and cross-referenced, leveraging advanced analytics for trend identification.

Why This Report Matters

  • Empowers executives to make evidence-based investment, procurement, and R&D decisions in an evolving therapeutic space.
  • Delivers detailed segmentation and actionable regional intelligence to support go-to-market optimization and risk mitigation planning.
  • Illustrates the strategic implications of regulatory, clinical, and supply-side trends to enhance competitive advantage.

Conclusion

The evolution of injectable ketamine represents both a challenge and a catalyst for innovation in global clinical treatment. Market-leading intelligence, as presented in this report, equips decision-makers to anticipate disruption, optimize strategies, and drive effective patient outcomes.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of subcutaneous ketamine formulations to improve patient accessibility and compliance
5.2. Integration of AI driven dosing algorithms in ketamine infusion centers to optimize treatment efficacy
5.3. Expansion of telemedicine enabled ketamine therapy sessions to reach underserved rural populations
5.4. Rising investment in clinical trials for adjunctive ketamine treatments in treatment resistant depression
5.5. Regulatory scrutiny intensifies over off label ketamine use prompting stricter compliance protocols
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Injectable Ketamine Market, by Indication
8.1. Introduction
8.2. Anesthesia
8.3. Pain Management
8.4. Post-Traumatic Stress Disorder
8.5. Treatment-Resistant Depression
9. Injectable Ketamine Market, by Product Type
9.1. Introduction
9.2. Esketamine
9.2.1. Brand
9.2.2. Generic
9.3. Racemic Ketamine
10. Injectable Ketamine Market, by Route
10.1. Introduction
10.2. Intramuscular Injection
10.3. Intravenous Infusion
11. Injectable Ketamine Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Center
11.3. Hospital
11.4. Outpatient Clinic
12. Injectable Ketamine Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Retail Pharmacy
13. Injectable Ketamine Market, by Formulation
13.1. Introduction
13.2. Prefilled Syringe
13.3. Vial
14. Americas Injectable Ketamine Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Injectable Ketamine Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Injectable Ketamine Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Pfizer Inc.
17.3.2. Hikma Pharmaceuticals PLC
17.3.3. Fresenius Kabi AG
17.3.4. Viatris Inc.
17.3.5. Aspen Pharmacare Holdings Limited
17.3.6. Mallinckrodt Pharmaceuticals Holdings, Inc.
17.3.7. Teva Pharmaceutical Industries Ltd.
17.3.8. Sandoz International GmbH
17.3.9. B. Braun Melsungen AG
17.3.10. Baxter International Inc.
18. ResearchAI19. ResearchStatistics20. ResearchContacts21. ResearchArticles22. Appendix
List of Figures
FIGURE 1. INJECTABLE KETAMINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL INJECTABLE KETAMINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS INJECTABLE KETAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS INJECTABLE KETAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES INJECTABLE KETAMINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES INJECTABLE KETAMINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INJECTABLE KETAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INJECTABLE KETAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC INJECTABLE KETAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC INJECTABLE KETAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. INJECTABLE KETAMINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. INJECTABLE KETAMINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. INJECTABLE KETAMINE MARKET: RESEARCHAI
FIGURE 28. INJECTABLE KETAMINE MARKET: RESEARCHSTATISTICS
FIGURE 29. INJECTABLE KETAMINE MARKET: RESEARCHCONTACTS
FIGURE 30. INJECTABLE KETAMINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. INJECTABLE KETAMINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INJECTABLE KETAMINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL INJECTABLE KETAMINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY ANESTHESIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY POST-TRAUMATIC STRESS DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY POST-TRAUMATIC STRESS DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY TREATMENT-RESISTANT DEPRESSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY TREATMENT-RESISTANT DEPRESSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY BRAND, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY BRAND, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY RACEMIC KETAMINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY RACEMIC KETAMINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY INTRAMUSCULAR INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY INTRAMUSCULAR INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY INTRAVENOUS INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY INTRAVENOUS INFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL INJECTABLE KETAMINE MARKET SIZE, BY VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS INJECTABLE KETAMINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS INJECTABLE KETAMINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES INJECTABLE KETAMINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES INJECTABLE KETAMINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 89. CANADA INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 90. CANADA INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 91. CANADA INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 92. CANADA INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 93. CANADA INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2018-2024 (USD MILLION)
TABLE 94. CANADA INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2025-2030 (USD MILLION)
TABLE 95. CANADA INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 96. CANADA INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 97. CANADA INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. CANADA INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. CANADA INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. CANADA INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. CANADA INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 102. CANADA INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 103. MEXICO INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 104. MEXICO INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 105. MEXICO INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 106. MEXICO INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 107. MEXICO INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2018-2024 (USD MILLION)
TABLE 108. MEXICO INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2025-2030 (USD MILLION)
TABLE 109. MEXICO INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 110. MEXICO INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 111. MEXICO INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. MEXICO INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. MEXICO INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. MEXICO INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. MEXICO INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 116. MEXICO INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA INJECTABLE KETAMINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA INJECTABLE KETAMINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 175. GERMANY INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 176. GERMANY INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 177. GERMANY INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 178. GERMANY INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 179. GERMANY INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2018-2024 (USD MILLION)
TABLE 180. GERMANY INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2025-2030 (USD MILLION)
TABLE 181. GERMANY INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 182. GERMANY INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 183. GERMANY INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. GERMANY INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. GERMANY INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. GERMANY INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. GERMANY INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 188. GERMANY INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 189. FRANCE INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 190. FRANCE INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 191. FRANCE INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. FRANCE INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. FRANCE INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2018-2024 (USD MILLION)
TABLE 194. FRANCE INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2025-2030 (USD MILLION)
TABLE 195. FRANCE INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 196. FRANCE INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 197. FRANCE INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. FRANCE INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. FRANCE INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. FRANCE INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. FRANCE INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 202. FRANCE INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 217. ITALY INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 218. ITALY INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 219. ITALY INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. ITALY INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. ITALY INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2018-2024 (USD MILLION)
TABLE 222. ITALY INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2025-2030 (USD MILLION)
TABLE 223. ITALY INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 224. ITALY INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 225. ITALY INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. ITALY INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. ITALY INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. ITALY INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. ITALY INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 230. ITALY INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 231. SPAIN INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 232. SPAIN INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 233. SPAIN INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 234. SPAIN INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 235. SPAIN INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2018-2024 (USD MILLION)
TABLE 236. SPAIN INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2025-2030 (USD MILLION)
TABLE 237. SPAIN INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 238. SPAIN INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 239. SPAIN INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. SPAIN INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. SPAIN INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. SPAIN INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. SPAIN INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 244. SPAIN INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 274. SOUTH AFRICA INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 276. SOUTH AFRICA INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 287. DENMARK INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 288. DENMARK INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 289. DENMARK INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. DENMARK INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. DENMARK INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2018-2024 (USD MILLION)
TABLE 292. DENMARK INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2025-2030 (USD MILLION)
TABLE 293. DENMARK INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 294. DENMARK INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 295. DENMARK INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. DENMARK INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. DENMARK INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. DENMARK INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. DENMARK INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 300. DENMARK INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 301. NETHERLANDS INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 302. NETHERLANDS INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 303. NETHERLANDS INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 304. NETHERLANDS INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 315. QATAR INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 316. QATAR INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 317. QATAR INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 318. QATAR INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 319. QATAR INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2018-2024 (USD MILLION)
TABLE 320. QATAR INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2025-2030 (USD MILLION)
TABLE 321. QATAR INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 322. QATAR INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 323. QATAR INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. QATAR INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. QATAR INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. QATAR INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. QATAR INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 328. QATAR INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 329. FINLAND INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 330. FINLAND INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 331. FINLAND INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 332. FINLAND INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 333. FINLAND INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2018-2024 (USD MILLION)
TABLE 334. FINLAND INJECTABLE KETAMINE MARKET SIZE, BY ESKETAMINE, 2025-2030 (USD MILLION)
TABLE 335. FINLAND INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 336. FINLAND INJECTABLE KETAMINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 337. FINLAND INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 338. FINLAND INJECTABLE KETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 339. FINLAND INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 340. FINLAND INJECTABLE KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 341. FINLAND INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 342. FINLAND INJECTABLE KETAMINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 343. SWEDEN INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 344. SWEDEN INJECTABLE KETAMINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 345. SWEDEN INJECTABLE KETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 346. SWEDEN INJECTABLE KETAMINE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Injectable Ketamine Market report include:
  • Pfizer Inc.
  • Hikma Pharmaceuticals PLC
  • Fresenius Kabi AG
  • Viatris Inc.
  • Aspen Pharmacare Holdings Limited
  • Mallinckrodt Pharmaceuticals Holdings, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • B. Braun Melsungen AG
  • Baxter International Inc.

Related Topics

Related Reports

Ketamine-Assisted Psychotherapy - Pipeline Insight, 2025 - Product Image

Ketamine-Assisted Psychotherapy - Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Ketamine (CAS 6740-88-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Ketamine (CAS 6740-88-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 51 Pages
  • Global
From
Ketamine Hydrochloride (CAS 1867-66-9) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Ketamine Hydrochloride (CAS 1867-66-9) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Psychedelic Drugs: Market Share, and Growth Analysis by Product Type (LSD, Psilocybin, MDMA, Ketamine), Application, End User, Technology - Product Image

Psychedelic Drugs: Market Share, and Growth Analysis by Product Type (LSD, Psilocybin, MDMA, Ketamine), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Non-injectable GnRH Drugs Market - Global Forecast 2025-2030 - Product Image

Non-injectable GnRH Drugs Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.